A new type of pill for emergency contraception

Oct 05, 2010 By Rita Rubin

By year's end, U.S. women will have two types of emergency contraceptive pills to choose from.

Studies show that both of them effectively prevent after contraceptive failure or , but two major differences distinguish them: Only one is available without a prescription. The other is effective longer.

The approved Ella, which contains a compound called ulipristal, in August. Watson Pharmaceuticals says it will launch Ella before the end of the year.

Its competitors: Plan B One-Step and Next Choice, which contain levonorgestrol. The original Plan B, two pills taken 12 hours apart, won FDA approval in 1999. Last year, Teva Pharmaceuticals introduced Plan B One-Step, a single pill, and Watson introduced Next Choice, a generic version of the original two-step Plan B.

Whether having two types of emergency contraceptive pills will reduce the proportion of U.S. pregnancies that are unplanned, which now stands at about one-half, remains to be seen.

"We do not believe technology holds all the answers, but having two types of safe and effective emergency will increase the likelihood that a woman can access a product that works for her situation," a coalition of 20 women's health groups, including the American College of Obstetricians and Gynecologists, wrote in a June letter to the FDA.

Still, Watson spokesman Charlie Mayr says that "one of the problems is that a lot of women don't know that emergency contraceptives exist."

That worries James Trussell, head of Princeton's Office of Population Research. Trussell founded and has maintained the Emergency Contraception web site (ec.princeton.edu) since 1994.

Despite the health groups' letter to the FDA in support of Ella's approval, Trussell says, "you can't depend on doctors to spread the word about emergency contraception. My suspicion is it's fallen off the radar for many, because they know that women are going directly to the pharmacist for it."

But that's one of Plan B's advantages, says Amy Niemann, vice president and general manager for Teva Women's Health. Plan B was first available only by prescription, but four years ago the FDA OK'd over-the-counter sales to consumers age 18 and over (the FDA lowered the cutoff by a year in 2009).

"Quick and easy access to is really important to women getting it," she says.

The best way to prevent an unintended pregnancy is to use a primary contraceptive method -- birth control pill, condom -- consistently, Niemann says. If that fails, she says, get Plan B at a pharmacy as soon as possible. If more than three days have passed, Niemann says, use Ella.

Explore further: FDA OKs Cubist antibiotic for serious infections

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA panel to consider new 'morning-after pill'

Jun 08, 2010

A Food and Drug Administration advisory committee will meet June 17 to consider whether the agency should approve a new emergency contraceptive that studies show is more effective than Plan B, the only "morning-after pill" ...

FDA OKs morning-after pill retail sale

Aug 24, 2006

Over-the-counter sale of Plan B, or the morning-after contraceptive pill was approved by the U.S. Food and Drug Administration Thursday.

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.